Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Deanol Bitartrate
2. 2-dimethylaminoethanol (+)-bitartrate Salt
3. Dmae Bitartrate
4. Dimethylaminoethanol Tartrate
5. 2-dimethylaminoethanol L-hydrogentartrate
6. Deanol Bitartrate, Dmae
7. Schembl989096
8. Amy39488
9. Ls-13528
10. Ft-0612179
11. 2-(dimethylamino)ethanol 2,3-dihydroxysuccinate
12. (2r,3r)-2,3-dihydroxybutanedioic Acid 2-(dimethylamino)ethanol
| Molecular Weight | 239.22 g/mol |
|---|---|
| Molecular Formula | C8H17NO7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 239.10050188 g/mol |
| Monoisotopic Mass | 239.10050188 g/mol |
| Topological Polar Surface Area | 139 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 163 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate, including repackagers and relabelers. The FDA regulates (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate supplier is an individual or a company that provides (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate active pharmaceutical ingredient (API) or (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate finished formulations upon request. The (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate suppliers may include (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
(2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate GMP manufacturer or (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate GMP API supplier for your needs.
A (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate CoA (Certificate of Analysis) is a formal document that attests to (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate's compliance with (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate specifications and serves as a tool for batch-level quality control.
(2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia ((2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate EP), (2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((2-Hydroxyethyl)Dimethylammonium Hydrogen Tartrate USP).
LOOKING FOR A SUPPLIER?
